
Pfizer finally wins bidding war to acquire Metsera
Following a week-long bidding war with Novo Nordisk, Pfizer has acquired obesity drug specialists Metsera for $10 billion, thanks to an intervention by the US Federal Trade Commission (FTC). Metsera’s Board of Directors unanimously recommended that Metsera stockholders approve the adoption of the amended Pfizer merger agreement… Read More
